Francis Mussai

8PUBLICATIONS
26CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical biochemistry - amino acids and metabolites
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 25, 2023
Arginine dependency is a therapeutically exploitable vulnerability in chronic myeloid leukaemic stem cells.

Kevin M Rattigan, Martha M Zarou, Zuzana Brabcova

|Dec 15, 2022
Engineering amino acid uptake or catabolism promotes CAR T-cell adaption to the tumor environment.

Silvia Panetti, Nicola McJannett, Livingstone Fultang

|Nov 22, 2022
A randomised evaluation of low-dose Ara-C plus pegylated recombinant arginase BCT-100 versus low dose Ara-C in older unfit patients with acute myeloid leukaemia: Results from the LI-1 trial.

Francis Mussai, Carmela De Santo, Paul Cheng

|Jul 05, 2022
Characterisation of Expression the Arginine Pathway Enzymes in Childhood Brain Tumours to Determine Susceptibility to Therapeutic Arginine Depletion.

Eleanor Bishop, Monika Dimitrova, Alexander Froggatt

|May 23, 2022
G-CSF induces CD15+ CD14+ cells from granulocytes early in the physiological environment of pregnancy and the cancer immunosuppressive microenvironment.

Ebtehag Maneta, Livingstone Fultang, Jemma Taylor

|Nov 29, 2018
Targeting the arginine metabolic brake enhances immunotherapy for leukaemia.

Francis Mussai, Rachel Wheat, Evgenia Sarrou

Pageof 2

Frequent Collaborators

1 joint publications

Matthew Pugh

1 joint publications

Maria Estevez-Cebrero

1 joint publications

Simon Paine

1 joint publications

Richard G Grundy